CTNNBIP1 and breast cancer: Consistent with the tumor-suppressive effects of GSK-3β, APC, and ICAT, miR-1229 was upregulated in breast cancer, and its overexpression dramatically promoted breast cancer cell proliferation both in vitro and in vivo.